Obalon Therapeutics Inc., of San Diego, said it entered into an agreement to sell shares of its common stock for aggregate gross proceeds of $10 million in a private placement. The company will sell approximately 5.5 million shares of common stock at $1.82 each. It plans to use the proceeds for commercial operations, working capital and general corporate purposes.